To learn more about this report, request sample copy
North America remains the dominant region in the global acute bacterial skin and skin structure infections market and is estimated to hold 36.7% of the market share in 2024 due to factors such as high per capita healthcare expenditure and presence of many leading industry players in the region. The U.S. accounts for the largest share in the North American market due to wide availability of advanced treatment options and growing awareness about skin infections and their management. Moreover, the reimbursement.
Asia Pacific has emerged as the fastest growing regional market for acute bacterial skin and skin structure infections treatment. Countries like China, India, Japan and South Korea are witnessing increasing prevalence of various skin infections due to growing urbanization, expanding industrial sectors and changing lifestyles. Rising incidence of hospital-acquired and surgical-site skin infections have also boosted demand for effective antibacterial drugs in Asia Pacific nations. Growing medical tourism and rising per capita incomes have made advanced treatment more affordable in the region. Furthermore, the presence of many global pharmaceutical manufacturers in Asia Pacific through their regional production facilities ensures adequate supply and lower prices of drugs.
Acute Bacterial Skin And Skin Structure Infections Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients